A business in context
MYGN research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-11 | Donnelly Brian J | A · Grant / award | Common Stock | 5000.0 | 3.94 |
| 2026-06-11 | Raha Samraat S. | A · Grant / award | Common Stock | 3542.0 | 3.94 |
| 2026-06-08 | Kumar Rashmi | S · Sale | Common Stock | 15000.0 | 4.46 |
| 2026-06-04 | Davis Mark Steven | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Kumar Rashmi | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Newcomer Lee Nisley | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Reitan Colleen F | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Skovronsky Daniel | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Phanstiel S. Louise | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Dreismann Heinrich | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-04 | Bisaro Paul | A · Grant / award | Common Stock | 59701.0 | 0.0 |
| 2026-06-01 | Jampa Raj | A · Grant / award | Common Stock | 251889.0 | 0.0 |
| 2026-05-14 | Bisaro Paul | P · Purchase | Common Stock | 7500.0 | 3.69 |
| 2026-05-01 | Donnelly Brian J | F · Tax / exercise payment | Common Stock | 55975.0 | 4.8 |
| 2026-04-14 | Muzzey Dale | F · Tax / exercise payment | Common Stock | 946.0 | 4.91 |
| 2026-04-14 | Verratti Mark | F · Tax / exercise payment | Common Stock | 1069.0 | 4.91 |
Identity & relationships
SEC issuer · 0000899923MYRIAD GENETICS INC
Myriad Genetics (Germany)Myriad Rules-Based Medicine (United States)
- Legal Entity Identifier
- 52990044IHUOUMETT163
- GLEIF legal name
- Myriad Genetics, Inc.
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2021-07-14T05:31:46Z
Search names and former names
View Wikidata identity and references ↗
- Myriad Genetics · alias · wikidata
- Myriad Genetics (Germany) · subsidiary · wikidata
- Myriad Rules-Based Medicine (United States) · subsidiary · wikidata
- MYRIAD GENETICS INC · former SEC name · 1996-11-14 to 2026-09-04
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $837.60M | $891.59M |
| 2023-12-31 | $753.20M | $825.37M |
| 2022-12-31 | $678.40M | $773.92M |
| 2021-12-31 | $690.60M | $850.89M |
| 2020-12-31 | $557.10M | $718.76M |
| 2020-06-30 | $638.60M | $829.00M |
| 2019-06-30 | $851.10M | $1.12B |
| 2018-06-30 | $743.70M | $1.00B |